about
Correction: Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-TransplantOpioid analgesics and the risk of fractures in older adults with arthritisDisease risk score as a confounder summary method: systematic review and recommendationsAnalgesic use and risk of subsequent hypertension in apparently healthy menMetabolic abnormalities and risk for colorectal cancer in the physicians' health studyColorectal cancer after start of nonsteroidal anti-inflammatory drug usePropensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychoticsDrug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE ConsortiumMeta-analysis of genome-wide association studies of HDL cholesterol response to statins.Identifying specific chemotherapeutic agents in Medicare data: a validation studyData for cancer comparative effectiveness research: past, present, and future potential.A framework for understanding cancer comparative effectiveness research data needsEffect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adultsComparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancerDoubly robust estimation of causal effectsConfounding control in a nonexperimental study of STAR*D data: logistic regression balanced covariates better than boosted CART.Using claims data to predict dependency in activities of daily living as a proxy for frailty.Using Procedure Codes to Define Radiation Toxicity in Administrative Data: The Devil is in the Details.Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration.Predicting persistence to antidepressant treatment in administrative claims data: Considering the influence of refill delays and prior persistence on other medications.Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data.Confounder summary scores when comparing the effects of multiple drug exposuresNonexperimental comparative effectiveness research using linked healthcare databasesImpact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults.Validation of Medicaid Claims-based Diagnosis of Myocardial Infarction Using an HIV Clinical CohortPropensity score methods for confounding control in nonexperimental researchThiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data.Assessing the impact of propensity score estimation and implementation on covariate balance and confounding control within and across important subgroups in comparative effectiveness research.Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: An Analysis of the Beijing Pharmacovigilance DatabaseTopiramate use does not reduce flares of inflammatory bowel diseaseTemporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study)Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011The role of the c-statistic in variable selection for propensity score models.Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailtySubgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.Commentary: Balancing automated procedures for confounding control with background knowledgeMedication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction.Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results
P50
Q24606658-833243CE-E9EA-4969-9303-C420D38219EAQ24607425-E40500F9-C789-4B52-9212-75B1F45C377EQ26999267-FF6D4798-BA2A-41FC-8C49-40DD4CCBEEB6Q28191794-D4DDD3A3-F764-430B-932A-96D5DCCFC880Q28212410-A4424D01-FEDB-4AE0-881E-0FA2CF67BC45Q28218715-A75E5ECB-442D-4AE8-88EF-DB1EE1B2C2C6Q28487733-208660F6-F9D6-472F-ACA0-D0A76086B99DQ28550578-520C54C2-3F1E-406A-868B-6F5B8E97E086Q30276013-A19C07BD-AEE0-4A22-8B4B-C047D5B7877AQ30413422-5391D994-22D3-4C79-A9A0-CE61E4CD9C94Q30416509-01B983A7-A3CA-4A5F-A27B-D1B53CF6BFF8Q30416607-B539E421-243B-46C0-92DE-40926388DBE4Q30418160-FEA79FB0-4D0A-4AEF-93EE-9ED49BC2D119Q30418988-371BBBD8-1B84-41A1-8586-6BE6C5A8F8E8Q30422446-802E1CDE-3D53-43C3-A8CE-C6736E4A8D0FQ30499313-B96D592B-83A2-4A86-8E9F-A6A1723D3ABBQ30590458-83981746-6780-40E9-AE84-B1F9710AAA55Q30863566-24314A0D-D198-4D96-90B0-27E0D58904F8Q30878981-148140EE-7CF8-405A-8721-45516167D20EQ30993245-23641647-C3FC-42ED-AFEF-D2B32E403EF8Q31049668-C503ED71-97C3-4041-8AE2-47B124073EB5Q31060524-65719F1F-2D1F-4CC6-BD8F-50D99C7E8A9FQ33566259-FE886276-24BF-4DE0-832A-8C99FF015070Q33576469-013DDC61-253E-4BA2-BA37-634D010F1596Q33601225-3C9BB060-A954-4495-A532-F22AFD44BBE4Q33618727-05A1F908-3161-4CFE-B3CD-705CE112A746Q33654170-F0225627-0273-478E-B845-979B5885A292Q33694542-7D4C1CC0-E029-4F68-AB10-E3D41B55B8EBQ33704004-FE7A150F-69C8-4622-A901-119A9DA17BEDQ33749743-A44D416A-48DE-41E6-878D-E0BB53C09523Q33807261-8C61E02B-BF58-4ACB-8846-7F714A567D3AQ33821081-D6358A8F-3156-4145-8EC2-5C257FA73181Q33821627-E8821C1D-810F-465C-A117-5712BAD2775AQ33829788-27194B44-6228-473C-B7AB-7079DA28BA50Q33847653-469C578C-C72E-4BC4-903A-3D581EEA5F19Q33866201-174D10B3-9F54-4F4F-9628-297104BFB35FQ33908100-9E808DE6-DE71-4B47-B073-3A88823335DAQ33949956-F4229D98-F1A4-40F5-9D68-EE33B88D56AEQ33987962-4368F7EE-A7C6-408A-896C-482B55EF3382Q34001872-9AFD4591-9F89-4616-B74C-8B8D49BC36D5
P50
description
researcher
@en
wetenschapper
@nl
name
Til Stürmer
@en
Til Stürmer
@nl
type
label
Til Stürmer
@en
Til Stürmer
@nl
prefLabel
Til Stürmer
@en
Til Stürmer
@nl
P31
P496
0000-0002-9204-7177